Laboratory Corporation of America Holdings (LH)
| Market Cap | 25.99B |
| Revenue (ttm) | 16.55B |
| Net Income (ttm) | 2.76B |
| Shares Out | 95.70M |
| EPS (ttm) | 28.19 |
| PE Ratio | 9.63 |
| Forward PE | 16.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,989,346 |
| Open | 272.79 |
| Previous Close | 270.87 |
| Day's Range | 270.88 - 275.25 |
| 52-Week Range | 212.85 - 317.17 |
| Beta | 1.03 |
| Analysts | Strong Buy |
| Price Target | 342.57 (+26.1%) |
| Earnings Date | Feb 10, 2022 |
About LH
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for LH stock is "Strong Buy." The 12-month stock price forecast is 342.57, which is an increase of 26.14% from the latest price.
News
LabCorp (LH) Gains As Market Dips: What You Should Know
LabCorp (LH) closed at $271.57 in the latest trading session, marking a +0.26% move from the prior day.
5 Lucrative PEG Stocks for Value Investors
Here are five value stocks, ACI, LH, PSX, FDX and SWRAY, matching our criteria.
LabCorp (LH) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, LabCorp (LH) closed at $276.08, marking a -0.62% move from the previous day.
We have no upfront costs for our Covid tests, says Labcorp CEO
Adam Schechter, Labcorp CEO, joins 'Closing Bell' to discuss how it is managing the influx of Covid test requests.
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Po...
CLEVELAND, Jan. 12, 2022 /PRNewswire/ -- GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp's OmniSeq to support the analysis and reporting of OmniSeq...
LabCorp (LH) Gains But Lags Market: What You Should Know
LabCorp (LH) closed at $291.94 in the latest trading session, marking a +0.11% move from the prior day.
Why LabCorp (LH) is Poised to Beat Earnings Estimates Again
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LABORATORY CORPORATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Laboratory Corporation of America Holdings...
NEW YORK--(BUSINESS WIRE)-- #Corporation--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Laboratory Corporation of America Ho...
Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2021 before the market opens on Thu...
4 Momentum Picks Screened on Driehaus Strategy
COWN, LH, BBWI, and ARCB qualified as the momentum picks for the day, using the Driehaus strategy.
SHAREHOLDER ALERT: Robbins LLP Investigates Laboratory Corporation of America Holdings (LH) on Behalf of Shareholders
SAN DIEGO--(BUSINESS WIRE)---- $LH #invest--Laboratory Corporation of America Holdings' (LH) Prenatal Tests May be Inaccurate
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Laboratory Corporation o...
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Laboratory Corporat...
The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf...
LOS ANGELES--(BUSINESS WIRE)---- $LH #investors--The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of Investors
Best Value Stocks to Buy for January 6th
M, LH, and SEKEY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 6, 2022
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Laboratory Corporation of America Holdings ...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH) investors concer...
Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat a...
LabCorp (LH) Soars to 52-Week High, Time to Cash Out?
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LabCorp (LH) to Expand Oncology Portfolio With Latest Buyout
LabCorp's (LH) acquisition of PGDx will position the company at the forefront of driving better patient outcomes in oncology.
LH vs. WST: Which Stock Should Value Investors Buy Now?
LH vs. WST: Which Stock Is the Better Value Option?
5 Momentum Stocks Bargain Hunters Would Love Chasing
Given the prevailing sentiment in the market, Academy Sports (ASO), Avis Budget (CAR), Laboratory Corporation (LH), Penske Automotive (PAG) and West Fraser (WFG) are expected to give handsome returns to...
Labcorp Bolsters Liquid Biopsy Capabilities With $450M PGDx Acquisition
Laboratory Corp of America Holdings (NYSE: LH) has agreed to acquire Personal Genome Diagnostics Inc (PGDx), a cancer genomics firm with a portfolio of comprehensive liquid biopsy and tissue-based produ...
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comp...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc....
Here's Why You Should Add LabCorp (LH) to Your Portfolio Now
Investors are optimistic about LabCorp's (LH) strong third-quarter 2021 results and raised guidance.
Labcorp, Quidel: Omicron Brings Covid Testing Stocks Back In Focus
Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections - is up by 24% year-to-date, roughly in line with the S&P 500. While we...
LabCorp (LH) Upgraded to Strong Buy: What Does It Mean for the Stock?
LabCorp (LH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.